|
Mr. Nielsen held various positions in the Novo Nordisk business area which in 2000 became Novozymes A/S. The last four years before joining Novo Ventures he was deeply involved in designing the R&D strategy for the company's efforts in the Cereal Food area, resulting in the development and launch of novel recombinant lipase and amylase enzymes. Mr. Nielsen was previously involved in collaborations with Procter & Gamble, Danisco, and Quest International to identify new enzymes for the detergent and cereal food industry. He held positions in marketing and technical services in the textile and personal care area, and started his carrier in the field of large-scale manufacturing of enzymes. Mr. Nielsen serves on the boards of directors of Cell Biosciences, Inc., Protein Forest, Inc. and Reata Pharmaceuticals, Inc., and he is a former director of Panacos Pharmaceuticals, Inc., Nuevolution A/S, and CardioOptics, Inc. Jack Nielsen obtained his MSc in 1990 from the Technical University of Denmark, and his Master in Management of Technology from the Center for Technology, Economics and Management in Copenhagen in 2000. | 